NovoPen®4 Clinical Experience Programme: A Multicentre, Observational Study of NovoPen®4 on Treatment Satisfaction of Insulin Therapy in Type 1 or Type 2 Subjects With Diabetes Mellitus.
Phase of Trial: Phase IV
Latest Information Update: 25 Nov 2016
At a glance
- Drugs Insulin (Primary)
- Indications Type 1 diabetes mellitus; Type 2 diabetes mellitus
- Focus Therapeutic Use
- Sponsors Novo Nordisk
- 27 Jan 2012 Official Title amended as reported by ClinicalTrials.gov.
- 20 Aug 2009 Actual patient number (526) added as reported by ClinicalTrials.gov.
- 20 Aug 2009 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.